Try
INTEGRA LIFESCIENCES HOLDINGS CORP
IARTUnited States
104 filed reports · 709 financial concepts · 1 earnings calls · 0 media appearances
Filed reports
104 reports · Jun 2014 to Jun 2026Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 433 guidance figures, 10 commentary passages.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Current · 8-KSEC EDGAR | 55 | 428 | Jun 2014 to Jun 2026 |
| Quarterly · 10-QSEC EDGAR | 37 | 7,049 | Jun 2014 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 12 | 7,446 | Dec 2014 to Dec 2025 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q2 | 10-Q | Jun 30, 2026 | Jul 29, 2026 | 415 | Open |
| FY2026 Q2 | 8-K | Jun 30, 2026 | Jul 29, 2026 | 12 | Open |
| FY2026 Q1 | 8-K | Mar 31, 2026 | May 5, 2026 | 4 | Open |
| FY2026 Q1 | 10-Q | Mar 31, 2026 | May 5, 2026 | 273 | Open |
| FY2025 | 10-K | Dec 31, 2025 | Feb 26, 2026 | 1,156 | Open |
| FY2025 Q4 | 8-K | Dec 31, 2025 | Feb 26, 2026 | 12 | Open |
| FY2025 Q3 | 8-K | Sep 30, 2025 | Oct 30, 2025 | 4 | Open |
| FY2025 Q3 | 10-Q | Sep 30, 2025 | Oct 30, 2025 | 305 | Open |
| FY2025 Q2 | 10-Q | Jun 30, 2025 | Jul 31, 2025 | 211 | Open |
| FY2025 Q2 | 8-K | Jun 30, 2025 | Jul 31, 2025 | 6 | Open |
| FY2025 Q1 | 10-Q | Mar 31, 2025 | May 5, 2025 | 212 | Open |
| FY2025 Q1 | 8-K | Mar 31, 2025 | May 5, 2025 | 8 | Open |
Financial data
709 concepts · 14,923 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial679 concepts · 13,022 facts · Dec 2010 to Jul 2026
- Completed technology126 · Dec 2013 to Jun 2026
- Cash and cash equivalents at carrying value70 · Dec 2011 to Jun 2026
- Net income loss68 · Dec 2012 to Jun 2026
- Revenue68 · Dec 2012 to Jun 2026
- Amortization of intangible assets67 · Dec 2012 to Jun 2026
- Comprehensive income net of tax67 · Dec 2012 to Jun 2026
- Costs and expenses67 · Dec 2012 to Jun 2026
- Income tax expense benefit67 · Dec 2012 to Jun 2026
- Incremental common shares attributable to share based payment arrangements67 · Dec 2012 to Jun 2026
- Investment income interest67 · Dec 2012 to Jun 2026
- Operating income loss67 · Dec 2012 to Jun 2026
- Other nonoperating income expense67 · Dec 2012 to Jun 2026
- Selling general and administrative expense67 · Dec 2012 to Jun 2026
- Stockholders equity (US GAAP)67 · Dec 2011 to Jun 2026
- Deferred income tax expense benefit66 · Dec 2012 to Jun 2026
- Increase decrease in accounts payable and accrued liabilities66 · Dec 2012 to Jun 2026
- Increase decrease in accounts receivable66 · Dec 2012 to Jun 2026
- Increase decrease in inventories66 · Dec 2012 to Jun 2026
- Increase decrease in other noncurrent liabilities66 · Dec 2012 to Jun 2026
- Increase decrease in other operating assets66 · Dec 2012 to Jun 2026
- Increase decrease in prepaid deferred expense and other assets66 · Dec 2012 to Jun 2026
- Net cash provided by used in financing activities66 · Dec 2012 to Jun 2026
- Net cash provided by used in investing activities66 · Dec 2012 to Jun 2026
- Net cash provided by used in operating activities66 · Dec 2012 to Jun 2026
Segment17 concepts · 1,122 facts · Jun 2013 to Jun 2026
- Revenue427 · Jun 2013 to Jun 2026
- Operating income loss163 · Jun 2013 to Jun 2026
- Goodwill136 · Dec 2013 to Jun 2026
- Goodwill foreign currency translation gain loss105 · Mar 2016 to Jun 2026
- Codman Specialty Surgical56 · Mar 2015 to Jun 2026
- Amortization of intangible assets32 · Dec 2022 to Jun 2026
- Cost of goods and services sold (US GAAP)32 · Dec 2022 to Jun 2026
- Costs and expenses32 · Dec 2022 to Jun 2026
- Research and development expense excluding acquired in process cost32 · Dec 2022 to Jun 2026
- Selling general and administrative expense32 · Dec 2022 to Jun 2026
- Goodwill impairment loss21 · Jun 2014 to Dec 2025
- Goodwill translation adjustments19 · Sep 2014 to Dec 2015
- Goodwill acquired during period15 · Sep 2014 to Dec 2021
- Goodwill written off related to sale of business unit8 · Dec 2017 to Dec 2023
- Goodwill purchase accounting adjustments6 · Mar 2015 to Dec 2016
- Goodwill transfers5 · Dec 2020
- U.S. Spine1 · Dec 2013
Guidance7 concepts · 428 facts · Aug 2014 to Oct 2026
- Revenue Guidance156 · Aug 2014 to Oct 2026
- EPS (Diluted) Guidance127 · Aug 2014 to Jul 2026
- Revenue Growth Guidance48 · Feb 2016 to Jul 2026
- EPS (Diluted) Guidance (Adjusted (non-GAAP))30 · Apr 2015 to Oct 2026
- Revenue Growth Guidance (Organic)27 · Apr 2015 to Jul 2022
- Net Income Guidance22 · Aug 2014 to Oct 2019
- Net Income Guidance (Adjusted (non-GAAP))18 · Apr 2015 to Oct 2019
Geography1 concepts · 273 facts · Dec 2012 to Jun 2026
- Revenue273 · Dec 2012 to Jun 2026
Product5 concepts · 78 facts · Dec 2012 to Sep 2022
- Revenue45 · Dec 2012 to Sep 2022
- Segment Profit17 · Dec 2012 to Dec 2015
- Goodwill10 · Dec 2013 to Dec 2014
- Goodwill translation adjustments5 · Dec 2014
- U.S. Instruments1 · Dec 2014
Segments
1,473 factsFigures broken down by business line, region, product or another axis the company reports on.
Statement business segments25 members · 1,122 facts
- Codman Specialty Surgical362 · Dec 2015 to Jun 2026
- Tissue Technologies236 · Dec 2019 to Dec 2025
- Orthopedicsand Tissue Technologies170 · Mar 2014 to Dec 2020
- Specialty Surgical Solutions66 · Mar 2014 to Sep 2017
- Specialty Surgery43 · Mar 2025 to Jun 2026
- Codman specialty surgical42 · Dec 2016 to Dec 2025
- Tissue Reconstruction39 · Mar 2025 to Jun 2026
- Orthopedicsand tissue technologies31 · Dec 2014 to Dec 2020
- Tissue technologies26 · Dec 2020 to Dec 2025
- US Spine And Other16 · Jun 2013 to Jun 2015
- Specialty surgical solutions15 · Dec 2014 to Sep 2017
- Spine13 · Mar 2014 to Jun 2015
- International10 · Jun 2013 to Sep 2014
- US Extremities10 · Jun 2013 to Sep 2014
- US Instruments10 · Jun 2013 to Sep 2014
- US Neurosurgery10 · Jun 2013 to Sep 2014
- International3 · Dec 2013 to Sep 2014
- Specialty surgery3 · Dec 2025 to Jun 2026
- Tissue reconstruction3 · Dec 2025 to Jun 2026
- Usextremities3 · Dec 2013 to Sep 2014
- Usinstruments3 · Dec 2013 to Sep 2014
- Usneurosurgery3 · Dec 2013 to Sep 2014
- Usspine and other3 · Dec 2013 to Sep 2014
- Spine1 · Dec 2014
- U.S. Spine1 · Dec 2013
Statement geographicalsrt:StatementGeographicalAxis5 members · 193 facts
- Asia Pacific47 · Dec 2016 to Jun 2026
- Europe47 · Dec 2016 to Jun 2026
- US47 · Dec 2016 to Jun 2026
- Rest Of World38 · Dec 2016 to Sep 2024
- Rest Of The World14 · Dec 2022 to Jun 2026
Statement geographicalus-gaap:StatementGeographicalAxis4 members · 80 facts
- Europe26 · Dec 2012 to Mar 2018
- Rest Of World26 · Dec 2012 to Mar 2018
- US26 · Dec 2012 to Mar 2018
- Asia Pacific2 · Mar 2017 to Mar 2018
Product or serviceus-gaap:ProductOrServiceAxis15 members · 77 facts
- Instruments9 · Dec 2012 to Dec 2014
- Neurosurgery9 · Dec 2012 to Dec 2014
- Orthopedics9 · Dec 2012 to Dec 2014
- US Instruments9 · Dec 2012 to Dec 2015
- US Neurosurgery8 · Dec 2012 to Dec 2015
- International7 · Dec 2012 to Dec 2014
- US Extremities7 · Dec 2012 to Dec 2014
- US Spine And Other7 · Dec 2012 to Dec 2014
- Instruments us2 · Dec 2013 to Dec 2014
- International2 · Dec 2013 to Dec 2014
- Neurosurgery us2 · Dec 2013 to Dec 2014
- Usextremities2 · Dec 2013 to Dec 2014
- Usspine and other2 · Dec 2013 to Dec 2014
- Instruments Us1 · Dec 2014
- Neurosurgery Us1 · Dec 2014
Product or servicesrt:ProductOrServiceAxis1 member · 1 facts
- Product Return1 · Sep 2022
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
- Earnings-release commentary10 claims from 1 reports · Oct 2026
Earnings calls
1 calls · Jul 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q2Jul 29, 2026
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.